[Anti-tNFalpha therapy in chronic severe asthma].
Tomasiak
Maria Magdalena
MM
Klinika Alergologii i Chorób Wewnetrznych Akademii Medycznej w Białymstoku
Zietkowski
Ziemowit
Z
Tomasiak
Marian
M
Skiepko
Roman
R
Bodzenta-Lukaszyk
Anna
A
D018927:Anti-Asthmatic Agents / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy*; D000068800:Etanercept; D006801:Humans; D007074:Immunoglobulin G / Q000627:therapeutic use; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use; D012720:Severity of Illness Index; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D018927:Anti-Asthmatic Agents; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha; D000068800:Etanercept